Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02905240 · ClinicalTrials.gov registry record · NA
Saline-Controlled Study of nSTRIDE APS for Knee Osteoarthritis
A NA study, sponsored by Zimmer Biomet.
- Completed
- Registry status
- NA
- Development phase
- 332
- Enrollment target
NCT02905240: Completed NA study, sponsored by Zimmer Biomet.
NCT02905240 is a NA study that has completed, run by Zimmer Biomet. The registered enrollment target is 332 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02905240, a NA study, has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- NA
- Development phase
- 332 participants
- Enrollment target
Study Summary
A double-blind, multicenter, randomized, controlled trial (RCT) that will evaluate the efficacy of a single dose of Autologous Protein Solution (APS) in patients with Osteoarthritis (OA) of the knee.
Primary Outcome
The primary objective of this study was to determine whether nSTRIDE APS is superior to Saline with respect to the improvement in mean WOMAC Pain score (change from baseline to 12 Months post-injection raw score). The WOMAC pain subscale consisted of five questions scored from 0 to 4. The pain score has a range of 0 (no pain) to 20 (maximal pain).
Interventions
- DEVICE Saline
- DEVICE nSTRIDE APS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2016-11 |
| Est. Completion | 2020-06 |
| Phase | NA |
What the finished NCT02905240 record still lists
NCT02905240 is an interventional study that assigns participants to a tested intervention. The registered 332 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT02905240 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02905240 about?
NCT02905240 is a clinical study titled "Saline-Controlled Study of nSTRIDE APS for Knee Osteoarthritis". A double-blind, multicenter, randomized, controlled trial (RCT) that will evaluate the efficacy of a single dose of Autologous Protein Solution (APS) in patients with Osteoarthritis (OA) of the knee.
What is the current status of trial NCT02905240?
This trial is currently completed. It is a NA study. The enrollment target is 332 participants. The study started on 2016-11. Estimated completion is 2020-06.
What interventions are being tested in trial NCT02905240?
The interventions under investigation include: Saline (DEVICE), nSTRIDE APS (DEVICE).
Who is sponsoring clinical trial NCT02905240?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02905240's enrollment target sits among peer trials
332 306th of 2000 higher than 1,694 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174121 · 332 participants · Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- NCT02605785 · 332 participants · NA
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
- NCT04894006 · 332 participants · NA
Dementia Family Caregiver Study
- NCT05130606 · 332 participants · NA
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia